CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Growth in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDL) saw a significant increase in short interest in December. As of December 15th, there was short interest totalling 338,600 shares, an increase of 238.6% from the November 30th total of 100,000 shares. Based on an average daily trading volume, of 44,474,000 shares, the short-interest ratio is currently 0.0 days.

CBD Life Sciences Price Performance

CBDL stock traded up $0.00 during mid-day trading on Friday, hitting $0.00. The stock had a trading volume of 6,333,125 shares, compared to its average volume of 14,785,661. CBD Life Sciences has a 52 week low of $0.00 and a 52 week high of $0.03.

About CBD Life Sciences

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.